LUNG NEUROENDOCRINE NEOPLASM
Clinical trials for LUNG NEUROENDOCRINE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new LUNG NEUROENDOCRINE NEOPLASM trials appear
Sign up with your email to follow new studies for LUNG NEUROENDOCRINE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to keep early lung cancer from returning
Disease control OngoingThis study tests whether adding an immunotherapy drug (nivolumab) to precise, high-dose radiation (SABR) helps keep early-stage non-small cell lung cancer from coming back. About 140 people with stage I-IIA or recurrent lung cancer will be randomly assigned to get radiation alone…
Matched conditions: LUNG NEUROENDOCRINE NEOPLASM
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 07:58 UTC
-
New pill shows promise for rare cancers in early trial
Disease control OngoingThis study tests an experimental oral drug called CVM-1118 in 34 people with advanced neuroendocrine tumors that have not responded to standard treatments. The goal is to see if the drug can slow tumor growth or shrink tumors. Participants take the drug by mouth and are monitored…
Matched conditions: LUNG NEUROENDOCRINE NEOPLASM
Phase: PHASE2 • Sponsor: TaiRx, Inc. • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New study aims to ease the burden of neuroendocrine tumors
Knowledge-focused OngoingThis study follows over 2500 adults with neuroendocrine tumors (NETs) to learn how symptoms affect their lives and how doctors choose treatments. Participants fill out surveys about quality of life and care experiences over 18 months. The goal is to find the best ways to sequence…
Matched conditions: LUNG NEUROENDOCRINE NEOPLASM
Sponsor: University of Iowa • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC